Structure and functionality in flavivirus NS-proteins: Perspectives for drug design

Michela Bollati(University of Milan), Karin Álvarez(Centre National de la Recherche Scientifique), R. Assenberg(Centre for Human Genetics), Cécile Baronti, Bruno Canard(Architecture et Fonction des Macromolécules Biologiques), Shelley Cook(Natural History Museum), Bruno Coutard(Architecture et Fonction des Macromolécules Biologiques), Étienne Decroly(Architecture et Fonction des Macromolécules Biologiques), Xavier de Lamballerie, Ernest A. Gould(UK Centre for Ecology & Hydrology), Gilda Grard, Jonathan M. Grimes(Centre for Human Genetics), Rolf Hilgenfeld(University of Lübeck), Anna Jansson(Uppsala University), Hélène Malet(Architecture et Fonction des Macromolécules Biologiques), Erika J. Mancini(Centre for Human Genetics), Eloise Mastrangelo(University of Milan), Andrea Mattevi(University of Pavia), Mario Milani(University of Milan), Grégory Moureau, Johan Neyts(Rega Institute for Medical Research), Raymond J. Owens(Centre for Human Genetics), Jingshan Ren(Centre for Human Genetics), Barbara Selisko(Architecture et Fonction des Macromolécules Biologiques), Silvia Speroni(University of Pavia), H. Steuber(University of Lübeck), David I. Stuart(Centre for Human Genetics), Torsten Unge(Uppsala University), Martino Bolognesi(University of Milan)
Antiviral Research
November 28, 2009
Cited by 350Open Access
Full Text

Abstract

Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA genome. Besides yellow fever virus, a landmark case in the history of virology, members of the Flavivirus genus, such as West Nile virus and dengue virus, are increasingly gaining attention due to their re-emergence and incidence in different areas of the world. Additional environmental and demographic considerations suggest that novel or known flaviviruses will continue to emerge in the future. Nevertheless, up to few years ago flaviviruses were considered low interest candidates for drug design. At the start of the European Union VIZIER Project, in 2004, just two crystal structures of protein domains from the flaviviral replication machinery were known. Such pioneering studies, however, indicated the flaviviral replication complex as a promising target for the development of antiviral compounds. Here we review structural and functional aspects emerging from the characterization of two main components (NS3 and NS5 proteins) of the flavivirus replication complex. Most of the reviewed results were achieved within the European Union VIZIER Project, and cover topics that span from viral genomics to structural biology and inhibition mechanisms. The ultimate aim of the reported approaches is to shed light on the design and development of antiviral drug leads.


Related Papers

No related papers found

Powered by citation graph analysis